JP2009524428A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009524428A5 JP2009524428A5 JP2008552351A JP2008552351A JP2009524428A5 JP 2009524428 A5 JP2009524428 A5 JP 2009524428A5 JP 2008552351 A JP2008552351 A JP 2008552351A JP 2008552351 A JP2008552351 A JP 2008552351A JP 2009524428 A5 JP2009524428 A5 JP 2009524428A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acids
- cdr
- binding protein
- region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76302306P | 2006-01-27 | 2006-01-27 | |
| PCT/US2007/001687 WO2007089470A2 (en) | 2006-01-27 | 2007-01-23 | Antigen-binding proteins targeting s. aureus orf0657n |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009524428A JP2009524428A (ja) | 2009-07-02 |
| JP2009524428A5 true JP2009524428A5 (https=) | 2010-03-11 |
Family
ID=38327867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008552351A Withdrawn JP2009524428A (ja) | 2006-01-27 | 2007-01-23 | スタヒロコッカス・アウレウスｏｒｆ０６５７ｎを標的とする抗原結合タンパク質 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110091480A1 (https=) |
| EP (1) | EP1982185A4 (https=) |
| JP (1) | JP2009524428A (https=) |
| CN (1) | CN101375161A (https=) |
| AU (1) | AU2007210170A1 (https=) |
| CA (1) | CA2637152A1 (https=) |
| WO (1) | WO2007089470A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0811193A2 (pt) * | 2007-05-31 | 2014-11-11 | Merck & Co Inc | Proteína de ligação a antígeno isolada, ácido nucleico, célula recombinante, métodos para produzir uma proteína e para proteger ou tratar contra uma infecção por s. aureus em paciente, composição farmacêutica, uso da proteína de ligação a antígeno, e, polipeptídeo. |
| EP2185190B1 (en) | 2007-08-31 | 2015-06-24 | University Of Chicago | Methods and compositions related to immunizing against staphylococcal lung diseases and conditions |
| US9181329B2 (en) | 2007-08-31 | 2015-11-10 | The University Of Chicago | Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions |
| WO2010014304A1 (en) | 2008-07-29 | 2010-02-04 | University Of Chicago | Compositions and methods related to staphylococcal bacterium proteins |
| ES2784957T3 (es) | 2009-04-03 | 2020-10-02 | Univ Chicago | Composiciones y métodos relacionados con variantes de la proteína A (SPA) |
| JP6002128B2 (ja) | 2010-07-02 | 2016-10-05 | ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ | プロテインＡ（ＳｐＡ）変種に関連する組成物および方法 |
| US8945588B2 (en) | 2011-05-06 | 2015-02-03 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
| MX2021013833A (es) | 2019-05-14 | 2022-03-17 | Univ Chicago | Metodos y composiciones que comprenden variantes de la proteina a de estafilococos (spa). |
| WO2021051136A1 (en) | 2019-09-13 | 2021-03-18 | The University Of Chicago | Methods and compositions for treating staphylococcal infections |
| WO2022042673A1 (zh) * | 2020-08-28 | 2022-03-03 | 江苏恒瑞医药股份有限公司 | 用于降低异源多肽末端异质性的信号肽 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6916605B1 (en) * | 1990-07-10 | 2005-07-12 | Medical Research Council | Methods for producing members of specific binding pairs |
| PT1377314E (pt) * | 2001-01-26 | 2012-01-02 | Inhibitex Inc | Anticorpos monoclonais para a proteína clfa e método de utilização no tratamento ou prevenção de infecções |
| US20070275460A1 (en) * | 2003-03-03 | 2007-11-29 | Xencor.Inc. | Fc Variants With Optimized Fc Receptor Binding Properties |
| ATE457737T1 (de) * | 2003-07-24 | 2010-03-15 | Merck & Co Inc | Polypeptide zur induktion einer schützenden immunantwort gegen staphylococcus aureus |
| CN1980692A (zh) * | 2003-07-24 | 2007-06-13 | 麦克公司 | 用于诱导针对金黄色葡萄球菌的保护性免疫反应的多肽 |
| AU2006206577B2 (en) * | 2005-01-21 | 2012-03-08 | Merck Sharp & Dohme Corp. | Polypeptides for inducing a protective immune response against Staphylococcus aureus |
| EP2117574A4 (en) * | 2007-01-24 | 2010-06-16 | Merck Sharp & Dohme | POLYPEPTIDES FOR INDUCING A PROTECTIVE IMMUNE RESPONSE AGAINST STAPHYLOCOCCUS EPIDERMIDIS |
| EP2126070A4 (en) * | 2007-03-19 | 2010-03-31 | Merck Sharp & Dohme | POLYPEPTIDES FOR INDUCING A PROTECTIVE IMMUNE RESPONSE AGAINST STAPHYLOCOCCUS EPIDERMIDIS |
| BRPI0811193A2 (pt) * | 2007-05-31 | 2014-11-11 | Merck & Co Inc | Proteína de ligação a antígeno isolada, ácido nucleico, célula recombinante, métodos para produzir uma proteína e para proteger ou tratar contra uma infecção por s. aureus em paciente, composição farmacêutica, uso da proteína de ligação a antígeno, e, polipeptídeo. |
-
2007
- 2007-01-23 CN CNA2007800036232A patent/CN101375161A/zh active Pending
- 2007-01-23 AU AU2007210170A patent/AU2007210170A1/en not_active Abandoned
- 2007-01-23 US US12/223,110 patent/US20110091480A1/en not_active Abandoned
- 2007-01-23 EP EP07716897A patent/EP1982185A4/en not_active Withdrawn
- 2007-01-23 WO PCT/US2007/001687 patent/WO2007089470A2/en not_active Ceased
- 2007-01-23 JP JP2008552351A patent/JP2009524428A/ja not_active Withdrawn
- 2007-01-23 CA CA002637152A patent/CA2637152A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009524428A5 (https=) | ||
| TWI785583B (zh) | 一種抗新型冠狀病毒的單克隆抗體及其應用 | |
| CN116063464B (zh) | 冠状病毒的抗体或其抗原结合片段 | |
| RU2009149294A (ru) | Антиген-связывающие белки, нацеленные на orf0657n s.aureus | |
| US8298545B2 (en) | Anti-autoimmune antibodies for treatment of pemphigus | |
| CN111606993B (zh) | 抗呼吸道合胞病毒的全人广谱中和抗体4f1及其应用 | |
| CN102906111B (zh) | 特异性结合乙型肝炎病毒表面抗原的人抗体 | |
| CN115043938B (zh) | SARS-CoV-2及其突变株的抗体及应用 | |
| JP2011509245A5 (https=) | ||
| CN114644708B (zh) | 呼吸道合胞病毒特异性结合分子 | |
| CN109867723B (zh) | 抗人il6单克隆抗体及其制备方法和用途 | |
| JP2017505635A (ja) | 黄色ブドウ球菌特異的抗体、それを用いた治療方法及び検出方法 | |
| WO2020186687A1 (zh) | 一种特异性结合四种血清型登革病毒的人源抗体 | |
| JP2005514053A5 (https=) | ||
| CN117603358A (zh) | 一种广谱新型冠状病毒的双特异性抗体 | |
| US20240059764A1 (en) | ANTIGEN-BINDING PROTEIN TARGETING STAPHYLOCOCCUS AUREUS a-HEMOLYSIS AND APPLICATION THEREOF | |
| CN114805570B (zh) | 一种抗人ace2单克隆抗体及其应用 | |
| US20230183322A1 (en) | Method for preparing antigen-binding unit | |
| JP2023535233A (ja) | グリコシル化ｃｅａｃａｍ５に特異的に結合した抗体 | |
| CN114805579B (zh) | 一种抗人ace2蛋白单克隆抗体、核酸分子及应用 | |
| CN118085082A (zh) | 抗猫TNF-α单克隆抗体及其应用 | |
| CN117683123A (zh) | 抗狂犬病毒人源化抗体和抗体组合及其用途 | |
| CN113549146B (zh) | 针对柯萨奇病毒b1型的单克隆抗体及其用途 | |
| CN116606373A (zh) | 新型冠状病毒中和抗体及其用途 | |
| CN107417788A (zh) | 抗埃博拉病毒的中和性单克隆抗体 |